Establishment of a prognosis-related predictive model for hepatocellular carcinoma patients with macrovascular invasion treated with transcatheter arterial chemoembolization combined with intensity modulated radiotherapy.

IF 1.5 4区 医学 Q4 ONCOLOGY
Translational cancer research Pub Date : 2025-02-28 Epub Date: 2025-02-24 DOI:10.21037/tcr-24-1226
Dan Yang, Wanting Tian, Wei Wang, Xuan Zhao, Chaozhi Wang, Zhufang Ma
{"title":"Establishment of a prognosis-related predictive model for hepatocellular carcinoma patients with macrovascular invasion treated with transcatheter arterial chemoembolization combined with intensity modulated radiotherapy.","authors":"Dan Yang, Wanting Tian, Wei Wang, Xuan Zhao, Chaozhi Wang, Zhufang Ma","doi":"10.21037/tcr-24-1226","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>So far, there are still few studies on the prognostic factors of hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI) treated with transcatheter arterial chemoembolization (TACE) combined with intensity modulated radiotherapy (IMRT), and no relevant model has been established to predict the prognosis of such patients. Thus, the purpose of this study was to determine the prognostic factors of HCC patients with MVI after treatment with TACE combined with IMRT, and to establish a nomogram model for forecasting 1-, 3-, 5-year overall survival (OS) of the patients.</p><p><strong>Methods: </strong>HCC patients with MVI who were diagnosed and treated at Department of Gastroenterology, 3201 Hospital between January 2010 and December 2020 were enrolled in this study according to the inclusion and exclusion criteria. The risk factors linked to patient OS were determined by performing Cox regression analysis. The nomogram for predicting 1-, 3-, 5-year OS in HCC patients with MVI was stablished and validated based on the results of the Cox regression analysis.</p><p><strong>Results: </strong>In total, 118 patients were included in the current study. The medium follow-up time was 46 months (range, 29-71 months). Univariate Cox regression analysis revealed that tumor diameter, treatment frequency of TACE, IMRT dose, Child-Pugh grade, liver cirrhosis and alpha fetoprotein (AFP) level were significantly related to the OS of the patients. Further multivariate Cox regression analysis showed that treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were the independent prognostic factors of the OS in patients who were treated with TACE combined with IMRT. The nomogram we constructed using the above independent risk factors exhibited good ability for predicting 1-, 3-, 5-year OS of the patients. The concordance-index of the nomogram was 0.727, indicating the nomogram had a good discrimination.</p><p><strong>Conclusions: </strong>Treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were independent predictors of OS in HCC patients with MVI after TACE combined with IMRT treatment. The nomogram that we developed using these predictors provided a convenient tool to predict the survival probability in HCC patients with MVI.</p>","PeriodicalId":23216,"journal":{"name":"Translational cancer research","volume":"14 2","pages":"1214-1222"},"PeriodicalIF":1.5000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11912082/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational cancer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tcr-24-1226","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/24 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: So far, there are still few studies on the prognostic factors of hepatocellular carcinoma (HCC) patients with macrovascular invasion (MVI) treated with transcatheter arterial chemoembolization (TACE) combined with intensity modulated radiotherapy (IMRT), and no relevant model has been established to predict the prognosis of such patients. Thus, the purpose of this study was to determine the prognostic factors of HCC patients with MVI after treatment with TACE combined with IMRT, and to establish a nomogram model for forecasting 1-, 3-, 5-year overall survival (OS) of the patients.

Methods: HCC patients with MVI who were diagnosed and treated at Department of Gastroenterology, 3201 Hospital between January 2010 and December 2020 were enrolled in this study according to the inclusion and exclusion criteria. The risk factors linked to patient OS were determined by performing Cox regression analysis. The nomogram for predicting 1-, 3-, 5-year OS in HCC patients with MVI was stablished and validated based on the results of the Cox regression analysis.

Results: In total, 118 patients were included in the current study. The medium follow-up time was 46 months (range, 29-71 months). Univariate Cox regression analysis revealed that tumor diameter, treatment frequency of TACE, IMRT dose, Child-Pugh grade, liver cirrhosis and alpha fetoprotein (AFP) level were significantly related to the OS of the patients. Further multivariate Cox regression analysis showed that treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were the independent prognostic factors of the OS in patients who were treated with TACE combined with IMRT. The nomogram we constructed using the above independent risk factors exhibited good ability for predicting 1-, 3-, 5-year OS of the patients. The concordance-index of the nomogram was 0.727, indicating the nomogram had a good discrimination.

Conclusions: Treatment frequency of TACE and Child-Pugh grade, liver cirrhosis and AFP level were independent predictors of OS in HCC patients with MVI after TACE combined with IMRT treatment. The nomogram that we developed using these predictors provided a convenient tool to predict the survival probability in HCC patients with MVI.

背景:迄今为止,关于经导管动脉化疗栓塞术(TACE)联合调强放疗(IMRT)治疗有大血管侵犯(MVI)的肝细胞癌(HCC)患者预后因素的研究仍然很少,也没有建立预测此类患者预后的相关模型。因此,本研究的目的是确定MVI HCC患者接受TACE联合IMRT治疗后的预后因素,并建立预测患者1年、3年、5年总生存期(OS)的提名图模型。通过Cox回归分析确定了与患者OS相关的风险因素。根据Cox回归分析的结果,建立并验证了预测MVI HCC患者1年、3年和5年OS的提名图:本研究共纳入 118 例患者。中等随访时间为 46 个月(29-71 个月)。单变量Cox回归分析显示,肿瘤直径、TACE治疗频率、IMRT剂量、Child-Pugh分级、肝硬化和甲胎蛋白(AFP)水平与患者的OS显著相关。进一步的多变量考克斯回归分析表明,TACE治疗频率、Child-Pugh分级、肝硬化和甲胎蛋白水平是TACE联合IMRT治疗患者OS的独立预后因素。我们利用上述独立风险因素构建的提名图在预测患者1年、3年和5年的OS方面表现出良好的能力。提名图的一致性指数为0.727,表明提名图具有良好的辨别能力:结论:TACE治疗频率、Child-Pugh分级、肝硬化和AFP水平是TACE联合IMRT治疗后MVI HCC患者OS的独立预测因素。我们利用这些预测指标绘制的提名图为预测患有MVI的HCC患者的生存概率提供了一个便捷的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
252
期刊介绍: Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; http://tcr.amegroups.com/) is an Open Access, peer-reviewed journal, indexed in Science Citation Index Expanded (SCIE). TCR publishes laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer; results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving patients'' quality of life. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信